Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-030096

COO, CFO sold 4,500 shares at $33.75 ($151,875)

  • COO, CFO acquired 4,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kung Winston COO, CFO 2021-05-03 Option exercise +4,500 $3.22 $14,490 6,100 D: show line 1 in the form
Kung Winston COO, CFO 2021-05-03 Sale −4,500 $33.75 $151,875 1,600 D: show line 2 in the form
Open-market sales · 4,500 sh · avg $33.75 · $151,875

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kung Winston COO, CFO 2021-05-03 Option exercise · Stock Option (right to buy) −4,500 232,534 D: show line 3 in the form
Loading xslF345X03/doc4.xml…